Archives: Publications

• Cohen RV, Prager G, le Roux CW, Lingvay I, Salminen P. International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity Lancet Diabetes Endocrinol

• Coleman S, Lynch C, Worlikar H, Kelly E, Loveys K, Simpkin AJ, Walsh JC, Broadbent E, Finucane FM, O' Keeffe D. Digital Clinicians Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial JMIR Diabetes

• Smith L, López Sánchez GF, Veronese N, Soysal P, Tully MA, Kostev K, Butler L, Keyes H, Barnett Y, Shin JI, Koyanagi A. Physical multimorbidity and dynapenic abdominal obesity among older adults from low- and middle-income countries Commun Med (Lond)

• Hinwood NS, Casey MB, Dunlevy CG, Doody C, Blake C, Fullen BM, O'Donoghue G, Birney S, Fildes F, Smart KM. It Is a Vicious Circle: Experiences of People Living With Obesity and Chronic Pain: A Qualitative Evidence Synthesis (QES) Obes Rev

• Pack A, Grunstein R, Mokhlesi B, Ryan S, Schwab R, Gozal D. What will the impact be of use of tirzepatide in patients with obstructive sleep apnea (OSA)? Sleep

• Sherifali D, Racey M, Fitzpatrick-Lewis D, Greenway M, Sockalingam S, Wada J, Teoh SH, Patton I, Macklin D, van Rossum EFC, Busetto L, Horn DB, Patricia Nece JD, Leguede MEGS, Pearce N, Le Roux C, Ard J, Alberga AS, Kaplan L, Sharma AM, Wharton S. Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management Obes Rev

• Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP; SURMOUNT-5 Trial Investigators. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity N Engl J Med

• Parker CH, Slattery C, Brennan DJ, le Roux CW. Glucagon-like peptide 1 (GLP-1) receptor agonists’ use during pregnancy: Safety data from regulatory clinical trials Diabetes Obes Metab

• Al-Najim W, Raposo A, BinMowyna MN, le Roux CW. Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes Nutrients

• Davies MJ, Bajaj HS, Broholm C, Eliasen A, Garvey WT, le Roux CW, Lingvay I, Lyndgaard CB, Rosenstock J, Pedersen SD; REDEFINE 2 Study Group. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes N Engl J Med

  Insulin Resistance & Diabetes